VOLITIONRX LTD
{{company.company_channel.channel_name}}
Media Room
{{company.company_name_local}}
{{company.company_channel.channel_name}}
Company Profile
Media Room
VolitionRx Limited Schedules Full Year 2018 Earnings Conference Call and Business Update 2019-03-07 21:30
VolitionRx Limited to Expand its Nu.Q(TM) Trials to Veterinary Diagnostics 2018-10-04 21:00
VolitionRx Limited Releases Video Featuring Interviews with its Scientific Advisory Board 2018-09-26 21:00
VolitionRx Limited to Attend Multiple Conferences in September 2018-09-05 20:30
Preliminary Data from Study Demonstrates 94% Accuracy in Detecting Aggressive Prostate Cancer 2018-08-13 20:30
VolitionRx Announces $9 Million Private Placement 2018-08-08 18:00
VolitionRx Limited Schedules Second Quarter 2018 Earnings Conference Call and Business Update 2018-08-07 20:35
VolitionRx's First Research Use Only Product Is "On-The-Shelf" Today 2018-08-01 19:00
Volition Secures Additional $700,000 Non-Dilutive Funding from the Walloon Region 2018-07-02 20:30
VolitionRx Limited to Attend the Bank of America Merrill Lynch 2018 Health Care Conference from May 15-17, 2018 2018-05-14 21:00
VolitionRx Limited Announces First Quarter 2018 Financial Results and Business Update 2018-05-11 04:05
VolitionRx Signs a Global Sales and Distribution Agreement with Active Motif for its new RUO kits 2018-05-09 21:00
VolitionRx Limited Schedules First Quarter 2018 Earnings Conference Call and Business Update 2018-05-04 20:00
VolitionRx Announces Closing of $8.4 Million Public Offering of Common Stock 2018-03-14 04:05
VolitionRx Announces Pricing of $8.4 Million Public Offering of Common Stock 2018-03-09 22:10
VolitionRx Announces Proposed Underwritten Public Offering of Common Stock 2018-03-09 05:01
VolitionRx Appoints Harvard Professor, Dr. Lee-Jen Wei to Its Scientific Advisory Board 2018-03-07 21:30
VolitionRx Limited Schedules Full Year 2017 Earnings Conference Call and Business Update 2018-03-01 05:05
VolitionRx Limited Announces Interim Results from 680-Subject Clinical Trial in Colorectal Cancer 2018-02-27 05:05
VolitionRX Announces the Successful Conclusion of the Logistics and Pathway Design Study Conducted in Denmark. 2018-02-05 21:30
1 3 4 5 6 7 11